Skip to main content

Table 3 Summary of MS-based detection of SARS-CoV-2 viral peptides from clinical nasopharyngeal swab samples using the SISCAPA workflow

From: Correction: A SISCAPA-based approach for detection of SARS-CoV-2 viral antigens from clinical samples

 

Detection of SARS-CoV-2 viral peptides by SISCAPA approach

 

Positive

Negative

SARS-CoV-2 positive nasopharyngeal swab samples (n = 41)

38

3

Sensitivity—92.68%

SARS-CoV-2 negative nasopharyngeal swab samples (n = 30)

0

30

Specificity—100%